Company intelligence / Profile preview

RANCON Holdings

Ownership: Private
Development stage: Commercial

Overview

RANCON Holdings (part of the broader Rangs Group) operates active commercial businesses across pharmaceuticals and biotechnology among other sectors. Subsidiaries such as Rangs Pharmaceuticals Limited and Ranks Agro Biotech are engaged in the production of medicines and biotech products for the Bangladeshi market. Clinical results or investigational programs are not publicly detailed; operations appear to be focused on established commercial products.[3][5]

Modalities: Small moleculeBiologicPolymer-based drug delivery
Industry: Biotech

Beyond the preview

Go deeper on RANCON Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RANCON Holdings.

Explore the full profile